Yifeng Pharmacy Chain Co., Ltd. (603939.SS)
CNY 25.67
(-0.62%)
CNY 25.67
(-0.62%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 2.05 Billion CNY | 6.59% |
| 2022 | 1.88 Billion CNY | 40.83% |
| 2021 | 1.33 Billion CNY | 14.43% |
| 2020 | 1.17 Billion CNY | 43.48% |
| 2019 | 815.46 Million CNY | 41.01% |
| 2018 | 578.32 Million CNY | 35.38% |
| 2017 | 427.18 Million CNY | 44.01% |
| 2016 | 296.63 Million CNY | 27.39% |
| 2015 | 232.85 Million CNY | 25.99% |
| 2014 | 184.82 Million CNY | 39.18% |
| 2013 | 132.79 Million CNY | 45.16% |
| 2012 | 91.48 Million CNY | 22.46% |
| 2011 | 74.69 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 531.07 Million CNY | -9.71% |
| 2024 Q3 | 448.14 Million CNY | -15.62% |
| 2024 Q1 | 588.19 Million CNY | 6.11% |
| 2023 Q2 | 531.07 Million CNY | 5.87% |
| 2023 Q1 | 501.65 Million CNY | -24.92% |
| 2023 FY | 2 Billion CNY | 6.59% |
| 2023 Q4 | 554.34 Million CNY | 27.12% |
| 2023 Q3 | 436.08 Million CNY | -17.89% |
| 2022 Q4 | 668.16 Million CNY | 82.1% |
| 2022 Q3 | 366.92 Million CNY | -17.2% |
| 2022 Q2 | 443.12 Million CNY | 8.79% |
| 2022 Q1 | 407.31 Million CNY | 32.6% |
| 2022 FY | 1.88 Billion CNY | 40.83% |
| 2021 Q2 | 385.08 Million CNY | 7.03% |
| 2021 FY | 1.33 Billion CNY | 14.43% |
| 2021 Q1 | 359.8 Million CNY | 32.3% |
| 2021 Q3 | 286.8 Million CNY | -25.52% |
| 2021 Q4 | 307.17 Million CNY | 7.1% |
| 2020 Q2 | 335.96 Million CNY | 16.54% |
| 2020 Q3 | 273.84 Million CNY | -18.49% |
| 2020 Q4 | 271.95 Million CNY | -0.69% |
| 2020 FY | 1.17 Billion CNY | 43.48% |
| 2020 Q1 | 288.27 Million CNY | 52.95% |
| 2019 Q4 | 188.47 Million CNY | 10.2% |
| 2019 Q1 | 220.82 Million CNY | 45.63% |
| 2019 FY | 815.46 Million CNY | 41.01% |
| 2019 Q2 | 235.12 Million CNY | 6.47% |
| 2019 Q3 | 171.03 Million CNY | -27.26% |
| 2018 Q4 | 151.63 Million CNY | 29.55% |
| 2018 FY | 578.32 Million CNY | 35.38% |
| 2018 Q3 | 117.04 Million CNY | -29.41% |
| 2018 Q2 | 165.82 Million CNY | 15.3% |
| 2018 Q1 | 143.82 Million CNY | 10.59% |
| 2017 FY | 427.18 Million CNY | 44.01% |
| 2017 Q1 | 94.9 Million CNY | 13.08% |
| 2017 Q2 | 111.01 Million CNY | 16.97% |
| 2017 Q3 | 91.22 Million CNY | -17.83% |
| 2017 Q4 | 130.04 Million CNY | 42.56% |
| 2016 Q2 | 77.69 Million CNY | 9.99% |
| 2016 Q3 | 64.35 Million CNY | -17.17% |
| 2016 Q4 | 83.93 Million CNY | 30.41% |
| 2016 FY | 296.63 Million CNY | 27.39% |
| 2016 Q1 | 70.64 Million CNY | 3.34% |
| 2015 Q4 | 68.36 Million CNY | 43.85% |
| 2015 Q3 | 47.52 Million CNY | -21.67% |
| 2015 Q2 | 60.66 Million CNY | 7.75% |
| 2015 Q1 | 56.3 Million CNY | -3.91% |
| 2015 FY | 232.85 Million CNY | 25.99% |
| 2014 Q1 | 42.97 Million CNY | 0.0% |
| 2014 FY | 184.82 Million CNY | 39.18% |
| 2014 Q4 | 58.59 Million CNY | 54.47% |
| 2014 Q3 | 37.93 Million CNY | -16.3% |
| 2014 Q2 | 45.32 Million CNY | 5.47% |
| 2013 FY | 132.79 Million CNY | 45.16% |
| 2012 FY | 91.48 Million CNY | 22.46% |
| 2011 FY | 74.69 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Shanghai No.1 Pharmacy Co., Ltd. | 98.95 Million CNY | -1976.501% |
| Jointown Pharmaceutical Group Co., Ltd | 3.96 Billion CNY | 48.143% |
| LBX Pharmacy Chain Joint Stock Company | 1.39 Billion CNY | -46.967% |
| Yunnan Jianzhijia Health-Chain Co., Ltd. | 639.62 Million CNY | -221.251% |